Northern Trust
CLRB icon

Northern Trust’s Cellectar Biosciences CLRB Stock Holding History

Northern Trust’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Buy
+14,839
New +$41.5K ﹤0.01% 4291
2025
Q2 		– Sell
-2,600
Closed -$24.6K – 4423
2025
Q1 		$24.6K Hold
2,600
– – ﹤0.01% 4318
2024
Q4 		$23.3K Buy
2,600
+564
+28% +$26.1K ﹤0.01% 4362
2024
Q3 		$131K Hold
2,036
– – ﹤0.01% 3992
2024
Q2 		$153K Buy
2,036
+291
+17% +$27.9K ﹤0.01% 3943
2024
Q1 		$208K Buy
1,745
+1,322
+313% +$143K ﹤0.01% 3884
2023
Q4 		$35.1K Buy
+423
New +$31.5K ﹤0.01% 4295
2022
Q3 		– Sell
-318
Closed -$39K – 4722
2022
Q2 		$39K Hold
318
– – ﹤0.01% 4474
2022
Q1 		$66K Hold
318
– – ﹤0.01% 4465
2021
Q4 		$63K Hold
318
– – ﹤0.01% 4546
2021
Q3 		$88K Hold
318
– – ﹤0.01% 4433
2021
Q2 		$114K Hold
318
– – ﹤0.01% 4332
2021
Q1 		$154K Buy
318
+170
+115% +$101K ﹤0.01% 4178
2020
Q4 		$92K Buy
148
+64
+76% +$29.4K ﹤0.01% 4131
2020
Q3 		$31K Buy
+84
New +$33.2K ﹤0.01% 4154
2018
Q3 		– Sell
-10
Closed -$18K – 4314
2018
Q2 		$18K Hold
10
– – ﹤0.01% 4222
2018
Q1 		$33K Buy
10
+3
+43% +$10.7K ﹤0.01% 4123
2017
Q4 		$27K Buy
7
+2
+40% +$8.94K ﹤0.01% 4131
2017
Q3 		$28K Hold
5
– – ﹤0.01% 4121
2017
Q2 		$27K Hold
5
– – ﹤0.01% 4152
2017
Q1 		$37K Buy
+5
New +$29.7K ﹤0.01% 4087

Other funds holding CLRB

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Northern Trust's CLRB Position: Q2 2026 in Review

Northern Trust opened a new position in Cellectar Biosciences (CLRB) in Q2 2026: 14,839 shares worth $41.3K. The stake represents ﹤0.01% of the portfolio and ranks #4291 among its holdings. This is a return to the name: Northern Trust previously reported a position in CLRB as recently as Q1 2025.

Northern Trust first reported a position in CLRB in Q1 2017 and has held it in 21 quarters since. The position peaked at $208K in Q1 2024. 29 funds tracked by Wall St. Rank hold CLRB as of Q2 2026.

  • Northern Trust held 14,839 shares of Cellectar Biosciences worth $41.3K as of Q2 2026.
  • Cellectar Biosciences was a new Northern Trust position in Q2 2026.
  • Cellectar Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4291 holding.
  • Northern Trust first reported a position in Cellectar Biosciences in Q1 2017 and has held it in 21 quarters since.
  • Northern Trust's Cellectar Biosciences position peaked at $208K in Q1 2024.
  • 29 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.